
-
Kenya's economy faces climate change risks: World Bank
-
Dollar slides, stocks diverge as US-China trade war escalates
-
UK parliament to be recalled Saturday to discuss British Steel's future
-
JPMorgan Chase sees 'considerable turbulence' facing economy as profits rise
-
Trump's trade whiplash sends dollar into tailspin
-
Dollar slides, stocks diverge as China hits back at US tariffs
-
Elegance of the Edwardians on display at Buckingham Palace
-
Massive black hole 'waking up' in Virgo constellation
-
Dollar, stocks hit and gold hits record as trade war panic returns
-
Xi calls for EU, China to resist Trump trade war 'bullying'
-
Apple’s iPhone 16 hits Indonesia stores after monthslong ban
-
Sweden drowns in discarded fast fashion items
-
Despite US tariffs pause, southern African economies under threat
-
AI only just beginning to revolutionize the NBA game
-
Despite Trump pause, overall US tariff rate at highest in a century
-
'A pain that doesn't subside' at funerals for Dominican nightclub disaster victims
-
US auto union praises some Trump tariffs
-
Tesla opens first showroom in oil-rich Saudi
-
Oscars to add new award for stunts
-
Argentina braves 24-hour strike as it awaits word on IMF loan
-
Why did a Dominican nightclub roof cave in?
-
US-China trade war surges, overshadowing Trump climbdown
-
Charles and Camilla visit Dante's tomb, Byzantine mosaics
-
OpenAI countersues Musk as feud deepens
-
Global plastic recycling rates 'stagnant' at under 10%: study
-
Miuccia Prada's path from activist to top designer
-
Pope in surprise St Peter's visit a day after meeting King Charles
-
Wall Street rally fizzles as tariff worries resurface
-
US consumer inflation cools in March on falling gas prices
-
Cannes Festival: Films in competition
-
Cartier exhibition to bedazzle London crowds
-
Shanghai finance workers worry after front-row seat to tariff turmoil
-
Charles and Camilla visit tomb of Dante, Italy's greatest poet
-
EU halts counter-tariffs but no pause in US-China trade war
-
Scarlett Johansson to star at Cannes as festival unveils line-up
-
Trump tariffs weigh on Germany as institutes cut forecasts
-
Stocks zoom higher as Trump delays painful tariffs
-
Vatican releases image of Charles, Camilla meeting pope
-
Taiwan's TSMC says first quarter revenue up 42 percent
-
Vietnam says it will start trade talks with United States
-
Expo 2025 in Japan: five things to know
-
Trump's tariff pause gives market relief, but China trade war intensifies
-
Papua New Guinea lifts ban on forest carbon credits
-
Asian stocks crack higher as Trump delays painful tariffs
-
Cannes to unveil film selection under pressure over industry abuse
-
Companies keen to start deep-sea mining off Norway
-
China consumer prices slump for second straight month: data
-
Amazon satellite launch scrubbed due to weather
-
Bahrain Launches Informational Website and Hotline for the Golden Residency to Attract Global Professionals and Investors
-
US stocks soar on Trump tariff reversal, oil prices jump

What is microRNA? Nobel-winning discovery explained
The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical breakthroughs.
But while several treatments and tests are under development using microRNAs against cancer, heart disease, viruses and other illnesses, none have actually yet reached patients.
And the world paid little attention when the new Nobel laureates Victor Ambros and Gary Ruvkun revealed their discovery decades ago, thinking it was just "something weird about worms", Cambridge University geneticist Eric Miska told AFP.
Here is an explainer about how exactly these tiny genetic switches work inside our bodies.
- What is microRNA? -
Each cell in the human body has the same set of instructions, called DNA. Some turn into brain cells, while others become muscles.
So how do the cells know what to become? The relevant part of the DNA's instructions is pointed to via a process called gene regulation.
Ribonucleic acid (RNA) normally serves as a messenger. It delivers the instructions from the DNA to proteins, which are the building blocks of life that turn cells into brains -- or muscles.
Miska gave the example of the messenger RNA vaccines rolled out against Covid-19 during the pandemic, which insert a message with new instructions to build proteins that block viruses.
But the two new Nobel winners Ambros and Ruvkun discovered a whole new type of gene regulator that had previously been overlooked by science.
Rather than being the messenger which relays information, microRNA instead acts as a switch to turn other genes off and on.
"This was a whole new level of control that we had totally missed," said Miska, who has worked on microRNA for two decades, including with the new Nobel laureates.
"The discovery of microRNAs brought an additional level of complexity by revealing that regions that were thought to be non-coding play a role in gene regulation," French researcher Benoit Ballester told AFP.
- What did the Nobel winners do? -
Back in the 1980s, Ambros and Ruvkun had been working separately on how genes interact in one-millimetre-long roundworms called C.elegans.
When they compared their work, it led to the discovery of microRNA. Ambros revealed the finding in a 1993 paper.
"Nobody really paid much attention," Miska said, explaining that most scientists at the time thought it only applied to worms.
Then in 2000, Ruvkun published research showing that microRNA is present right across the animal kingdom, including in humans and even some viruses.
"This was not just something weird that worms do, but in fact all animals and plants are totally dependent for development and normal function on them," Miska said.
More than a thousand genes that respond to microRNAs are now believed to be in the human body.
- How could this help us? -
There are numerous new treatments and tests using microRNA that are undergoing trials but none have been made widely available.
"Though there are no very clear applications available yet in microRNAs, understanding them, knowing that they exist, understanding their counter-regulatory networks, is always the first step," the Karolinska Institute's Gunilla Karlsson Hedestam told journalists in Stockholm.
MicroRNAs are particularly promising for fighting cancer because some of these switches "act as a tumour suppressor, so they put a brake on cells dividing inappropriately," Miska said.
Others, meanwhile, induce "cells to divide, which can lead to cancer", he added.
Because many viruses use microRNAs, several antiviral drugs are at varying stages of development, including for hepatitis C.
One complicating factor has been that microRNAs can be unstable.
But scientists also hope they can be used as a test called a "biomarker", which could reveal what type of cancer a patient could be suffering from, for example.
- What next? -
It also appears probable that microRNAs could be involved in the evolution of our species, Miska said.
While human brains are difficult to study, Miska hoped future research will discover more.
H.Cho--CPN